SYNAGIS

Google image searchProduct monograph

Active ingredient

palivizumab, 50 MG/0.5 ML

DIN: 02438372

Dosage form(s): SOLUTION

Route(s) of administration: INTRAMUSCULAR

Description: 0.5ML SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: ASTRAZENECA CANADA INC

Date: 24-MAR-2022

ATC:

• J06 — IMMUNE SERA AND IMMUNOGLOBULINS (ATC, ATC/DDD, )
• J06B — IMMUNOGLOBULINS (ATC, ATC/DDD)
• J06BD — Antiviral monoclonal antibodies (ATC, ATC/DDD)
• J06BD01 — PALIVIZUMAB (ATC/DDD)

Reference brand drug: Synagis

External Links for Synagis

Search on Google

• Synagis side effects
• Synagis dosage
• palivizumab side effects
• palivizumab dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find synagis photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.